Takeaways: Kye Pharmaceuticals’ launch of Dyanavel XR in Canada adds a first-and-only chewable/swallowable extended-release amphetamine for ADHD in adults and children 6–12 years, alig...
Browsing Tag: neurodevelopmental disorders
Takeaways: Kye Pharmaceuticals’ launch of Dyanavel XR in Canada adds a first-and-only chewable/swallowable extended-release amphetamine for ADHD in adults and children 6–12 years, alig...